Polymer-drug conjugates as inhalable drug delivery systems: A review

Abstract

Abstract:Accelerating interest by the pharmaceutical industry in the identification and development of less invasive routes of nanomedicine administration, coupled with defined efforts to improve the treatment of respiratory diseases through inhaled drug administration has fuelled growing interests in inhalable polymer-drug conjugates. Polymer-drug conjugates can alter the pharmacokinetics profile of the loaded drug after inhaled administration and enable the controlled and sustained exposure of the lungs to drugs when compared to the inhaled or oral administration of the drug alone. However, the major concern with the use of inhalable polymer-drug conjugates is their biocompatibility and long-term safety with the lungs, which is closely linked to their retention time in the lungs. A detailed understanding about the pharmacokinetics, lung disposition, clearance and safety of inhaled polymer-drug conjugates with significant translational potential is therefore required. This review therefore provides a comprehensive summary of the latest developments on several types of polymer-drug conjugates that are currently being explored as inhalable drug delivery systems. Finally, the current status and future perspective of the polymer-drug conjugates is also discussed with a focus on current knowledge gaps. Graphical abstract:

Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs

“…They can also be formulated from branched polymeric carriers such as polymeric micelles and poly (amidoamine) (PAMAM) and poly (ethyleneimine) dendrimers [99]. They exhibit several unique advantages such as targeted drug delivery, biocompatibility, non-toxicity, enhanced drug water solubility, improved drug stability, and drug bioavailability [100][101][102].…”

Combination Therapy Strategies for the Treatment of Malaria

“…There are several polymers that can be used for the formulation of these carriers such as polyaspartamides, polyglutamic acid, polyamidoamine carriers, etc. The advantages of polymer–drug conjugates include improved drug solubility, reduced drug toxicity, enhanced drug biodegradability and bioavailability [57], improved pharmacodynamics, pharmacokinetics, and pharmacological properties [58]. Polymer-based carriers can be utilized for combination therapy, which is very useful for the treatment of different diseases.…”

Towards Universal Stimuli-Responsive Drug Delivery Systems: Pillar[5]arenes Synthesis and Self-Assembly into Nanocontainers with Tetrazole Polymers

“…In recent years, the pharmaceutical industry has had an increasing interest in the development and methods of introducing nanosystems in the treatment of various diseases by encapsulating drugs in biocompatible polymer matrices [ 1 , 2 , 3 ]. The resulting polymer-drug associates can change the pharmacokinetic properties and profile of the loaded drug after administration and provide a controlled and long-term effect of drugs on disease foci in comparison with the effect of the drug itself [ 1 , 2 , 3 ]. In addition, the polymer shell protects the loaded drug from premature biotransformation and can transport the drug to the focus of the disease practically without damage [ 1 ].…”

“…The resulting polymer-drug associates can change the pharmacokinetic properties and profile of the loaded drug after administration and provide a controlled and long-term effect of drugs on disease foci in comparison with the effect of the drug itself [ 1 , 2 , 3 ]. In addition, the polymer shell protects the loaded drug from premature biotransformation and can transport the drug to the focus of the disease practically without damage [ 1 ]. Water-soluble polymer systems occupy a special place among such drug delivery systems (DDSs) [ 4 , 5 ].…”